Form 4 for DGX Quest Diagnostics
Accepted 2025-10-24 00:00:00 ET · period of report 2025-10-22 · accession 0001022079-25-000228 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-24 | 2025-10-22 | DGX | PFEIFFER GARY M | Dir | S - Sale | $182.40 | -1,482 | 29.4K | -5% | -$270.3K |
| D | 2025-10-24 | 2025-10-23 | DGX | PFEIFFER GARY M | Dir | I - Discretionary | $190.58 | -4,413 | 0 | -100% | -$841.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-22 | S | D | 1,482 | $182.40 | 29,431 | D | — | — | |
| 2 | Derivative | Phantom Stock | 2025-10-23 | I | D | 4,413.28 | $190.58 | 0 | D | — · — to — | 4,413.28 Common Stock | (F1) This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock. |